An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents

The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy
David HeberV L Go

Abstract

Some strains of Chinese red yeast rice, when prepared by solid fermentation, produce compounds called monacolins that inhibit cholesterol production. When used as a dietary supplement to achieve and maintain healthy cholesterol levels, Chinese red yeast rice has significant potential to reduce health care costs and contribute to public health by reducing heart disease risk in individuals with moderate elevations of circulating cholesterol levels. Whereas one proprietary strain of Chinese red yeast rice has been demonstrated to lower cholesterol levels significantly in clinical trials, other strains being sold as Chinese red yeast rice dietary supplements have not undergone similar evaluation. In order to determine whether the results of a clinical trial conducted with one strain of Chinese red yeast rice could be generalized to other preparations of Chinese red yeast rice, nine different commercially available dietary supplements were purchased tested for chemical constituents. Monacolins were measured by high performance liquid chromatography (HPLC) that separates the various monacolins in Chinese red yeast rice. Citrinin concentration, a toxic fermentation byproduct, was measured by radioimmunoassay. Total monacolin content v...Continue Reading

References

Aug 1, 1976·The Journal of Antibiotics·A Endo, M Kuroda
Jan 1, 1990·Annual Review of Microbiology·R L Monaghan, J S Tkacz
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A W AlbertsJ Springer
May 1, 1981·The Journal of Antibiotics·G Albers-SchönbergA A Patchett
Jun 5, 1998·JAMA : the Journal of the American Medical Association·T A Pearson
Feb 16, 1999·The American Journal of Clinical Nutrition·D HeberV L Go
Nov 23, 2000·Journal of Agricultural and Food Chemistry·J MaM Chang

❮ Previous
Next ❯

Citations

Oct 27, 2009·Current Atherosclerosis Reports·Mary P McGowan, Suzanne Proulx
Nov 10, 2010·Current Atherosclerosis Reports·Ram Y Gordon, David J Becker
May 26, 2005·International Journal of Food Microbiology·Fusheng Chen, Xiaoqing Hu
Feb 21, 2008·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·M W Trucksess, P M Scott
Aug 15, 2009·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·Jose Diana Di MavunguSarah De Saeger
Jan 10, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Zhaoping LiDavid Heber
Feb 1, 2011·Cancer Prevention Research·Mee Young HongDavid Heber
Jun 5, 2014·Canadian Journal of Physiology and Pharmacology·Marwan AbdelbasetAzza M Agha
Jul 20, 2010·Scandinavian Cardiovascular Journal : SCJ·Martin Prøven BogsrudKjetil Retterstøl
Sep 29, 2011·Journal of Pharmaceutical and Biomedical Analysis·Fenhong SongRobert E Smith
Jul 30, 2011·The Urologic Clinics of North America·Mark A Moyad, Laurence H Klotz
Jul 21, 2010·The American Journal of Cardiology·David A Mark
Dec 3, 2010·Journal of Clinical Lipidology·Prabhjot S NijjarDaniel J Rader
Feb 27, 2010·The American Journal of Cardiology·Carmelo V VeneroPaul D Thompson
Sep 8, 2009·Progress in Cardiovascular Diseases·Mark C HoustonDean A Bramlet
Jul 21, 2009·Primary Care·Stacy Loeb, Edward M Schaeffer
Jul 11, 2008·Mayo Clinic Proceedings·David J BeckerNayyar Iqbal
Feb 1, 2008·Journal of Clinical Lipidology·Venkateshwar R PolsaniVijay Nambi
Jul 7, 2014·European Journal of Internal Medicine·Massimo R MannarinoMatteo Pirro
Feb 19, 2013·Journal of Clinical Lipidology·Lindsey ChildressMatthew K Ito
Apr 1, 2008·Chinese Medicine·Ricky W K Wong, Bakr Rabie
Nov 2, 2011·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Fumiko HigashikawaMasanori Sugiyama
Nov 6, 2013·Critical Reviews in Food Science and Nutrition·Jinyi YangDharini Sivakumar
Oct 19, 2006·The Annals of Pharmacotherapy·Leslie K NiesKari L Olson
Mar 28, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Emanuel RaschiFabrizio De Ponti
Jun 16, 2017·European Journal of Preventive Cardiology·Guy G De Backer
Jun 24, 2017·European Journal of Preventive Cardiology·Pieter A CohenIkhlas A Khan
May 18, 2018·Journal of Mass Spectrometry : JMS·Leonardo Di DonnaFabio Mazzotti
Sep 2, 2017·Chinese Journal of Integrative Medicine·Min WuLong-Tao Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

The American Journal of Medicine
Rodrigo Cartin-CebaAnna Kolpakchi
Scandinavian Cardiovascular Journal : SCJ
Martin Prøven BogsrudKjetil Retterstøl
Journal of Clinical Lipidology
Venkateshwar R PolsaniVijay Nambi
© 2021 Meta ULC. All rights reserved